Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 April 2005, Vol. 105, No. 7, pp. 2671-2676.
Prepublished online as a Blood First Edition Paper on December 2, 2004; DOI 10.1182/blood-2004-09-3509.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-09-3509v1
105/7/2671    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martinez-Duncker, I.
Right arrow Articles by Mollicone, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martinez-Duncker, I.
Right arrow Articles by Mollicone, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted September 9, 2004
Accepted November 26, 2004

Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter

Ivan Martinez-Duncker*, Thierry Dupre, Veronique Piller, Friedrich Piller, Jean-Jacques Candelier, Catherine Trichet, Gil Tchernia, Rafael Oriol, and Rosella Mollicone

INSERM U504, GDR CNRS 2590, University of Paris Sud XI, Villejuif, France
Laboratoire de biochimie A, Hopital Bichat, Claude Bernard AP-HP, Paris, France
Laboratoire de biochimie A, Centre de Biophysique Moleculaire-CNRS UPR4301, Orleans, France
Laboratoire d'Hematologie, Immunologie et Cytogenetique, Hopital Kremlin-Bicetre, Kremlin-Bicetre, France

* Corresponding author; email: martinez{at}vjf.inserm.fr.

We have identified a homozygous G >A substitution in the donor splice site of the intron 6 (IVS6+1G >A) of the CMP-sialic acid transporter gene of Lec2 cells, as the mutation responsible for their asialo-phenotype. These cells were used in complementation studies, to test the activity of the two CMP-sialic acid transporter cDNA alleles of a patient devoid of sialyl-Lex expression on polymorphonuclear cells. No complementation was obtained with either of the two patient alleles, whereas full restoration of the sialylated phenotype was obtained in the Lec2 cells transfected with the corresponding human wild type transcript. The inactivation of one patient allele, by a double microdeletion inducing a premature stop codon at position 327, and a splice mutation of the other allele inducing a 130 bp deletion and a premature stop codon at position 684, are proposed to be the causal defects of this disease. A four base insertion in the intron 6 was found in the mother and is proposed to be responsible for the splice mutation. We conclude that this defect is a new type of congenital disorder of glycosylation (CDG) of type IIf, affecting the transport of CMP-sialic acid into the Golgi.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Crispin, V. T. Chang, D. J. Harvey, R. A. Dwek, E. J. Evans, D. I. Stuart, E. Y. Jones, J. M. Lord, R. A. Spooner, and S. J. Davis
A Human Embryonic Kidney 293T Cell Line Mutated at the Golgi {alpha}-Mannosidase II Locus
J. Biol. Chem., August 7, 2009; 284(32): 21684 - 21695.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
E. Jamroz, D. Adamek, J. Paprocka, M. Adamowicz, E. Marszal, and R. A. Wevers
CDG Type Ia and Congenital Cytomegalovirus Infection: Two Coexisting Conditions
J Child Neurol, January 1, 2009; 24(1): 13 - 18.
[Abstract] [PDF]


Home page
GlycobiologyHome page
T. Miyazaki, K. Angata, P. H. Seeberger, O. Hindsgaul, and M. Fukuda
CMP substitutions preferentially inhibit polysialic acid synthesis
Glycobiology, February 1, 2008; 18(2): 187 - 194.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Perez-Cerda, D. Quelhas, A. I. Vega, J. Ecay, L. Vilarinho, and M. Ugarte
Screening Using Serum Percentage of Carbohydrate-Deficient Transferrin for Congenital Disorders of Glycosylation in Children with Suspected Metabolic Disease
Clin. Chem., January 1, 2008; 54(1): 93 - 100.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Wopereis, S. Grunewald, K. M.L.C. Huijben, E. Morava, R. Mollicone, B. G.M. van Engelen, D. J. Lefeber, and R. A. Wevers
Transferrin and Apolipoprotein C-III Isofocusing Are Complementary in the Diagnosis of N- and O-Glycan Biosynthesis Defects
Clin. Chem., February 1, 2007; 53(2): 180 - 187.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Zhao, T.-L. L. Chen, B. M. Vertel, and K. J. Colley
The CMP-sialic Acid Transporter Is Localized in the Medial-Trans Golgi and Possesses Two Specific Endoplasmic Reticulum Export Motifs in Its Carboxyl-terminal Cytoplasmic Tail
J. Biol. Chem., October 13, 2006; 281(41): 31106 - 31118.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Johnson and E. S. Bennett
Isoform-specific Effects of the beta2 Subunit on Voltage-gated Sodium Channel Gating
J. Biol. Chem., September 8, 2006; 281(36): 25875 - 25881.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Thiel, T. Lubke, G. Matthijs, K. von Figura, and C. Korner
Targeted Disruption of the Mouse Phosphomannomutase 2 Gene Causes Early Embryonic Lethality
Mol. Cell. Biol., August 1, 2006; 26(15): 5615 - 5620.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
R. D. Cohn, E. Eklund, A. L. Bergner, J. F. Casella, S. L. Woods, J. Althaus, K. J. Blakemore, H. E. Fox, J. E. Hoover-Fong, A. Hamosh, et al.
Intracranial Hemorrhage as the Initial Manifestation of a Congenital Disorder of Glycosylation
Pediatrics, August 1, 2006; 118(2): e514 - e521.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Helmus, J. Denecke, S. Yakubenia, P. Robinson, K. Luhn, D. L. Watson, P. J. McGrogan, D. Vestweber, T. Marquardt, and M. K. Wild
Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter
Blood, May 15, 2006; 107(10): 3959 - 3966.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Wopereis, D. J. Lefeber, E. Morava, and R. A. Wevers
Mechanisms in Protein O-Glycan Biosynthesis and Clinical and Molecular Aspects of Protein O-Glycan Biosynthesis Defects: A Review
Clin. Chem., April 1, 2006; 52(4): 574 - 600.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
B. Thomsen, P. Horn, F. Panitz, E. Bendixen, A. H. Petersen, L.-E. Holm, V. H. Nielsen, J. S. Agerholm, J. Arnbjerg, and C. Bendixen
A missense mutation in the bovine SLC35A3 gene, encoding a UDP-N-acetylglucosamine transporter, causes complex vertebral malformation
Genome Res., January 1, 2006; 16(1): 97 - 105.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
S. Wopereis, E. Morava, S. Grunewald, M. Adamowicz, K. M. L. C. Huijben, D. J. Lefeber, and R. A. Wevers
Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups
Glycobiology, December 1, 2005; 15(12): 1312 - 1319.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020